Literature DB >> 28570697

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0176984.].

Entities:  

Year:  2017        PMID： 28570697      PMCID： PMC5453612          DOI： 10.1371/journal.pone.0179139

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The affiliation for the last author is incorrect. Takanori Shibata is not affiliated with #6 but with #2 Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan. The publisher apologizes for the error.
  1 in total

1.  High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.

Authors:  Hirokazu Honda; Tetsuo Michihata; Kanji Shishido; Keiko Takahashi; Go Takahashi; Nozomu Hosaka; Misa Ikeda; Daisuke Sanada; Takanori Shibata
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240
  1 in total
  1 in total

1.  Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.

Authors:  Anna Jovanovich; Zhiying You; Tamara Isakova; Kristen Nowak; Alfred Cheung; Myles Wolf; Michel Chonchol; Jessica Kendrick
Journal:  Am J Nephrol       Date:  2019-02-28       Impact factor: 3.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.